Stockholders’ Equity (Deficit) (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Dec. 31, 2025 |
| Equity [Abstract] |
|
|
| Schedule of Fair Value of Options Granted Black-Scholes-Merton Model |
There
were no options granted during the three months ended March 31, 2026. The assumptions used to determine the fair value of options
granted in the three months ended March 31, 2025 using the Black-Scholes-Merton model are as follows:
Schedule
of Fair Value of Options Granted Black-Scholes-Merton Model
| Dividend yield | |
| - | % |
| Risk-free interest rate | |
| 3.62 to 4.23 | % |
| Expected volatility (weighted-average and range, if applicable) | |
| 100 | % |
| Expected term | |
| 6 to 6.5 years | |
|
The
assumptions used to determine the fair value of options granted in the year ended December 31, 2025 using the Black-Scholes-Merton option
model are as follows:
Schedule
of Fair Value of Options Granted Black-Scholes-Merton Model
| Dividend yield | |
| - | |
| Risk-free interest rate | |
| 3.5%
to 4.4 | % |
| Expected volatility | |
| 93.4%
to 115.5 | % |
| Expected term in years | |
| 5
to 6.5 | |
The
assumptions used to determine the fair value of options granted in the year ended December 31, 2024 using the Black-Scholes-Merton
model are as follows:
| Dividend yield | |
| 0 | % |
| Risk-free interest rate | |
| 3.6%
to 4.2 | % |
| Expected volatility | |
| 100 | % |
| Expected term in years | |
| 6
to 6.5 | |
|
| Schedule of Stock Option Activities and Related Information |
A
summary of the Company’s stock option activities and related information for the three-month ended March 31, 2026 is
as follows:
Schedule
of Stock Option Activities and Related Information
| Stock Option | |
No. of Stock
Option | | |
Weighted-Average
Exercise Price | | |
Weighted-Average
Remaining
Contractual Life
(in Years) | |
| January 1, 2026 | |
| 538,618 | | |
$ | 11.25 | | |
| 9.3 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| - | | |
| - | | |
| - | |
| March 31, 2026 | |
| 538,618 | | |
$ | 11.25 | | |
| 9.0 | |
| Vested and expected to vest, March 31, 2026 | |
| 538,618 | | |
$ | 11.25 | | |
| 9.0 | |
A
summary of the Company’s stock option activities and related information for the three months ended March 31, 2025 is as follows:
| Stock Option | |
No. of Stock
Option | | |
Weighted-Average
Exercise Price | | |
Weighted-Average
Remaining
Contractual Life
(in Years) | |
| January 1, 2025 | |
| 105,090 | | |
$ | 98.55 | | |
| 0.7 | |
| Granted | |
| 127,153 | | |
| 3.40 | | |
| 1.3 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| (20,731 | ) | |
| (69.07 | ) | |
| - | |
| March 31, 2025 | |
| 211,512 | | |
$ | 44.24 | | |
| 1.0 | |
|
A
summary of the Company’s stock option activities and related information for the year ended December 31, 2025 is as follows:
Schedule
of Stock Option Activities and Related Information
| Stock
Option | |
No.
of Stock Option | | |
Weighted-Average Grant
Date Exercise
Price | | |
Weighted-Average Remaining Contractual
Life (In
Years) | |
| Balance, January 1, 2025 | |
| 105,090 | | |
$ | 98.55 | | |
| 0.65 | |
| Granted | |
| 540,827 | | |
| 3.89 | | |
| 9.5 | |
| Forfeited | |
| (107,299 | ) | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| - | | |
| - | | |
| - | |
| Balance, December
31, 2025 | |
| 538,618 | | |
$ | 11.25 | | |
| 9.3 | |
| Vested and expected
to vest December 31, 2025 | |
| 538,618 | | |
$ | 11.25 | | |
| 9.3 | |
| Stock
Option | |
No.
of Stock Option | | |
Weighted-Average
Grant Date
Exercise Price
| | |
Weighted- Average Remaining Contractual
Life (In
Years) | |
| January 1, 2024 | |
| 114,301 | | |
$ | 108.62 | | |
| 1.65 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| (9,211 | ) | |
| (76.60 | ) | |
| - | |
| December 31, 2024 | |
| 105,090 | | |
$ | 98.55 | | |
| 0.65 | |
|
| Schedule of Options Outstanding |
The following
options were outstanding at their respective exercise price on March 31, 2026 and December 31, 2025, respectively:
Schedule
of Options Outstanding
| Exercise Price Options Outstanding | |
March 31, 2026 | | |
December 31, 2025 | |
| $1.27 | |
| 25,000 | | |
| 25,000 | |
| $2.22 | |
| 23,781 | | |
| 23,781 | |
| $2.40 | |
| 364,893 | | |
| 364,893 | |
| $6.40 | |
| 7,326 | | |
| 7,326 | |
| $7.80 | |
| 5,731 | | |
| 5,731 | |
| $8.00 | |
| 32,700 | | |
| 32,700 | |
| $9.68 | |
| 34,884 | | |
| 34,884 | |
| $31.20 | |
| 9,978 | | |
| 9,978 | |
| $62.54 | |
| 6,825 | | |
| 6,825 | |
| $133.40 | |
| 27,500 | | |
| 27,500 | |
| Total | |
| 538,618 | | |
| 538,618 | |
|
The
following options were outstanding as of December 31, 2025, at their respective exercise price:
Schedule of Options Outstanding
| Exercise Price
Options Outstanding | |
December
31, 2025 | |
| $1.27 | |
| 25,000 | |
| $2.22 | |
| 23,781 | |
| $2.40 | |
| 364,893 | |
| $6.40 | |
| 7,326 | |
| $7.80 | |
| 5,731 | |
| $8.00 | |
| 32,700 | |
| $9.68 | |
| 34,884 | |
| $31.20 | |
| 9,978 | |
| $62.54 | |
| 6,825 | |
| $133.40 | |
| 27,500 | |
| Total | |
| 538,618 | |
|
| Schedule of Stock Compensation Expenses |
Stock
compensation expenses are comprised of the following:
Schedule
of Stock Compensation Expenses
| | |
2026 | | |
2025 | |
| | |
For The Three Months Ended | |
| | |
2026 | | |
2025 | |
| Compensation and employee benefits | |
$ | 58,908 | | |
$ | 152,266 | |
| Professional services | |
| - | | |
| 588,993 | |
| Total | |
$ | 58,908 | | |
$ | 741,259 | |
|
Stock
compensation expenses is comprised of the following:
Schedule of Stock Compensation Expenses
| |
|
2025 |
|
|
2024 |
|
| |
|
Year
Ended December 31 |
|
| |
|
2025 |
|
|
2024 |
|
| Compensation
and employee benefits |
|
$ |
796,565 |
|
|
$ |
1,575,952 |
|
| Professional
services |
|
|
688,993 |
|
|
|
- |
|
| Total |
|
$ |
1,485,558 |
|
|
$ |
1,575,952 |
|
|
| Schedule of Restricted Stock Units |
The
Company did not have any outstanding restricted stock units (“RSUs”) as of March 31, 2026. A summary of the Company’s
RSU activity and related information for the three months ended March 31, 2025 is presented below:
Schedule
of Restricted Stock Units
| Restricted Stock Units | |
No. of RSU | | |
Weighted-Average Grant Date Fair Value
Per RSU | | |
Weighted-Average
Remaining
Contractual Life
(in Years) | |
| January 1, 2025 | |
| 8,583 | | |
$ | 26.20 | | |
| 1.00 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Vested | |
| (4,292 | ) | |
| 26.20 | | |
| - | |
| Expired | |
| - | | |
| - | | |
| | |
| Cancelled / Forfeited | |
| (980 | ) | |
| - | | |
| - | |
| March 31, 2025 | |
| 3,311 | | |
$ | 26.20 | | |
| 0.8 | |
|
A
summary of the Company’s RSU activities and related information for the year ended December 31, 2025 and December 31, 2024 is as
follows:
Schedule of Restricted Stock Units
| Restricted
Stock Units | |
No.
of RSU | | |
Weighted-
Average Grant Date Fair Value Per RSU | | |
Weighted-
Average Remaining Contractual Life (in Years) | |
| January 1, 2025 | |
| 8,583 | | |
$ | 26.20 | | |
| 1.00 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Vested | |
| (5,740 | ) | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| (2,843 | ) | |
| - | | |
| - | |
| December 31, 2025 | |
| - | | |
| - | | |
| - | |
| Restricted
Stock Units | |
No.
of RSU | | |
Weighted-
Average Grant Date Fair Value Per RSU | | |
Weighted-
Average Remaining Contractual Life (in Years) | |
| January 1, 2024 | |
| 16,175 | | |
$ | 26.20 | | |
| 2.00 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Vested | |
| (5,392 | ) | |
| 26.20 | | |
| - | |
| Expired | |
| - | | |
| - | | |
| - | |
| Cancelled / Forfeited | |
| (2,200 | ) | |
| 26.20 | | |
| - | |
| December 31, 2024 | |
| 8,583 | | |
| 26.20 | | |
| 1.00 | |
|